Clinical Trial Update: A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose trial evaluating safety, tolerability and pharmacokinetics of NNC0361-0041 in Type 1 diabetes mellitus; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NNC0361-0041

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type I Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2025-05-20